Skip to Content

Dexamethasone Sodium Phosphate Injection

Last Updated: July 6, 2018
Status: Current

Products Affected - Description
    • Dexamethasone Sodium Phosphate injection, American Regent, 4 mg/mL, 1 mL single dose vial, 25 count, NDC 00517-4901-25
    • Dexamethasone Sodium Phosphate injection, American Regent, 4 mg/mL, 30 mL multiple dose vial, 25 count, NDC 00517-4930-25
    • Dexamethasone Sodium Phosphate injection, American Regent, 4 mg/mL, 5 mL multiple dose vial, 25 count, NDC 00517-4905-25
    • Dexamethasone Sodium Phosphate injection, AuroMedics, 4 mg/mL, 1 mL vial, 25 count, NDC 55150-0237-01
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0106-10
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 30 mL multiple dose vial, 1 count, NDC 63323-0165-30
    • Dexamethasone Sodium Phosphate injection, Hikma, 4 mg/mL, 1 mL vial, 25 count, NDC 00641-6145-25
    • Dexamethasone Sodium Phosphate injection, Hikma, 4 mg/mL, 5 mL vial, 25 count, NDC 00641-6146-25
Reason for the Shortage
    • American Regent has dexamethasone sodium phosphate on shortage due to manufacturing delays.
    • AuroMedics has dexamethasone sodium phosphate on intermittent back order.
    • Fresenius Kabi has dexamethasone sodium phosphate presentations available.
    • Mylan Institutional has dexamethasone sodium phosphate available.
    • Hikma did not provide a reason for the shortage.
Available Products
    • Dexamethasone Sodium Phosphate injection, AuroMedics, 4 mg/mL, 30 mL vial, 25 count, NDC 55150-0239-30
    • Dexamethasone Sodium Phosphate injection, AuroMedics, 4 mg/mL, 5 mL vial, 25 count, NDC 55150-0238-05
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 1 mL preservative-free single dose vial, 25 count, NDC 63323-0506-01
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 10 mg/mL, 10 mL multiple dose vial, 10 count, NDC 63323-0516-10
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 1 mL single dose vial, 25 count, NDC 63323-0165-01
    • Dexamethasone Sodium Phosphate injection, Fresenius Kabi, 4 mg/mL, 5 mL multiple dose vial, 25 count, NDC 63323-0165-05
    • Dexamethasone Sodium Phosphate injection, Hikma, 10 mg/mL, 1 mL vial, 25 count, NDC 00641-0367-25
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional, 10 mg/mL, 10 mL vial, 10 count, NDC 67457-0420-10
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional, 4 mg/mL, 1 mL vial, 25 count, NDC 67457-0423-12
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional, 4 mg/mL, 30 mL vial, 25 count, NDC 67457-0421-30
    • Dexamethasone Sodium Phosphate injection, Mylan Institutional, 4 mg/mL, 5 mL vial, 25 count, NDC 67457-0422-54

Estimated Resupply Dates

    • American Regent has dexamethasone sodium phosphate 4 mg/mL products on back order and the company cannot estimate a release date.
    • AuroMedics has dexamethasone sodium phosphate 4 mg/mL 1 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Fresenius Kabi has dexamethasone sodium phosphate 4 mg/mL 1 mL prefilled syringes on back order and the company estimates a release date of 4th quarter 2018. The 4 mg/mL 30 mL vials are on back order and the company estimates a release date in late-July 2018.
    • Hikma has dexamethasone sodium phosphate 4 mg/mL 1 mL and 5 mL vials on back order and the company cannot estimate a release date.

Updated

Updated July 6, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 18, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide